Newsletter SignupSearch


Discovery of Novel Blood Biomarkers for PTSD and TBI

Biological Psychiatry 2018; 83(9): S134-135. Supplement
Authored By:
Fossati S, Cejudo JR, Genfi A, Abu-Amara D, Marmar C
The development of blood biomarkers for PTSD and TBI is an extremely critical area of research. Easily detectable blood biomarkers are needed for diagnostic purposes, to establish therapeutic efficacy, to better understand the biology underlying these disorders.
Published in:
Biological Psychiatry

More Publications

September 9, 2022


Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable Sensors

June 1, 2022

JAMA Network Open

Association of Posttraumatic Stress Disorder With Accelerated Cognitive Decline in Middle-aged Women

March 23, 2022

Journal of Neurotrauma

A Framework to Advance Biomarker Development in the Diagnosis, Outcome Prediction, and Treatment of Traumatic Brain Injury

February 26, 2022

Translational Psychiatry

Plasma biomarkers associated with deployment trauma and its consequences in post-9/11 era veterans: initial findings from the TRACTS longitudinal cohort

January 31, 2022

Biological Psychiatry

Noncoding RNAs: Stress, Glucocorticoids, and Posttraumatic Stress Disorder

December 1, 2021

Neurotrauma Reports

Neurotrauma Reports Special Collection: Null Hypothesis Initiative

Cohen Veterans Bioscience - Advancing Brain Health

Get the latest updates in TBI and PTSD research

Sign up for our newsletter to learn how we’re advancing solutions for brain trauma.

This field is for validation purposes and should be left unchanged.